MGHNeurology Profile Banner
MGH Neurology Profile
MGH Neurology

@MGHNeurology

Followers
8K
Following
3K
Media
569
Statuses
3K

On a mission to find new treatments and cures to eliminate the devastating impact of neurological disorders.

Boston, MA
Joined March 2013
Don't wanna be here? Send us removal request.
@MGHNeurology
MGH Neurology
10 hours
You can read the full paper here:
0
1
1
@MGHNeurology
MGH Neurology
10 hours
This international collaborative review shares the recent advances in primary lateral sclerosis (PLS), a neurodegenerative disorder. Collaborative efforts are paving the way for the first clinical trials for PLS. Stay tuned to learn more about the next #PLSResearch gathering.
1
3
3
@MGHNeurology
MGH Neurology
1 day
RT @BWHNeurology: Registration is now open for Sleep Medicine 2025! This program explores the critical role of sleep in medical and psychia….
0
2
0
@MGHNeurology
MGH Neurology
2 days
RT @NataliaRostMD: And here you go, our first @MGHNeurology C. Miller Fisher #StrokeService team of the new academic year 🙌 🧠✅ So much exc….
0
4
0
@MGHNeurology
MGH Neurology
4 days
Please join us on Thursday, 7/10, at 5:00 pm ET for a brief presentation and Q&A session on Expanded Access Protocols (EAPs), featuring guest speaker Dr. Rick Bedlack of Duke University. Register:
Tweet media one
0
4
4
@MGHNeurology
MGH Neurology
7 days
Read more here:
0
1
1
@MGHNeurology
MGH Neurology
7 days
Check out this systematic review and meta-analysis in NeuroImage: Clinical. Researchers assessed 30 studies and found that changes in cervical spinal cord quantitative MRI (qMRI) are promising imaging markers for amyotrophic lateral sclerosis (ALS). #ALSResearch #HealeyHope.
1
2
3
@MGHNeurology
MGH Neurology
7 days
Read the full paper here: And the press release here: #HealeyHope.
0
1
2
@MGHNeurology
MGH Neurology
7 days
A recent paper proposes a novel way to fund drug development for amyotrophic lateral sclerosis (ALS). Using data from the HEALEY ALS Platform Trial, researchers found that this new approach could help overcome obstacles in financing ALS clinical trials and attract more investors.
2
4
11
@MGHNeurology
MGH Neurology
8 days
The Sean M. Healey & AMG Center for ALS is pleased to announce the successful integration of placebo data from the first five regimens of the HEALEY ALS Platform Trial into the PRO-ACT database. Read more: . #OpenScience #HealeyHope
Tweet media one
0
1
4
@MGHNeurology
MGH Neurology
10 days
RT @NataliaRostMD: Did my heart just skip a beat? 💓 . It’s July 1st at @MassGeneralNews and it never gets old. Twenty-three years later, it….
0
7
0
@MGHNeurology
MGH Neurology
10 days
RT @LivingwithSS: Keynote speaker Dr. Michael Levy, Superficial Siderosis Clinic and Research Lab @MGHNeurology Superficial Siderosis http….
0
2
0
@MGHNeurology
MGH Neurology
10 days
Check out the full interview here:
0
2
2
@MGHNeurology
MGH Neurology
10 days
Recently, Dr. Merit Cudkowicz sat down for an inspiring conversation with Mass General Brigham Neurology resident Dylan Neel. She discussed how she became interested in neuroscience and her passion for advancing clinical trials in amyotrophic lateral sclerosis (ALS). #ALSResearch.
2
6
11
@MGHNeurology
MGH Neurology
10 days
RT @MassGenBrigham: While there’s no cure for amyotrophic lateral sclerosis (ALS)—a disease that affects the motor neurons controlling move….
0
5
0
@MGHNeurology
MGH Neurology
10 days
RT @BWHNeurology: Congratulations to Dr. Trevor Balena on his promotion to Instructor in Neurology and appointment to the research faculty….
0
1
0
@MGHNeurology
MGH Neurology
10 days
RT @BWHNeurology: Welcome Dr. Sandro Marini to the Division of Neurocritical Care and the faculty at MGB Neurology beginning in July! @MGHN….
0
1
0
@MGHNeurology
MGH Neurology
10 days
RT @BWHNeurology: Welcome Dr. Daniel Chiu to the Division of Neuro-Oncology and the faculty at MGB Neurology beginning in July! @MGHNeurolo….
0
1
0
@MGHNeurology
MGH Neurology
10 days
RT @BWHNeurology: Welcome Dr. @NigamMinali to the Division of Headache and Facial Pain and the faculty at MGB Neurology beginning in July!….
0
2
0